Research Article

You have full text access to this OnlineOpen article

Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes

  1. Mona G. Sarkiss MD, PhD1,
  2. S. Wamique Yusuf MBBS, MRCPI2,
  3. Carla L. Warneke MD3,
  4. Gregory Botz MD1,
  5. Nasser Lakkis MD4,
  6. Cheryl Hirch-Ginsburg MD5,
  7. J. Chris Champion MD2,
  8. Joseph Swafford MD2,
  9. Andrew D. S. Shaw MD6,
  10. Daniel J. Lenihan MD2,
  11. Jean-Bernard Durand MD2,†,‡,*

Article first published online: 13 DEC 2006

DOI: 10.1002/cncr.22434

Issue

Cancer

Cancer

Volume 109, Issue 3, pages 621–627, 1 February 2007

Additional Information

How to Cite

Sarkiss, M. G., Yusuf, S. W., Warneke, C. L., Botz, G., Lakkis, N., Hirch-Ginsburg, C., Champion, J. C., Swafford, J., Shaw, A. D. S., Lenihan, D. J. and Durand, J.-B. (2007), Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes. Cancer, 109: 621–627. doi: 10.1002/cncr.22434

Author Information

  1. 1

    Departments of Anesthesiology and Critical Care, University of Texas M. D. Anderson Cancer Center, Houston, Texas

  2. 2

    Department of Cardiology, University of Texas M. D. Anderson Cancer Center, Houston, Texas

  3. 3

    Division of Quantitative Sciences, University of Texas M. D. Anderson Cancer Center, Houston, Texas

  4. 4

    Department of Cardiology, Baylor College of Medicine, Ben Taub General Hospital, Houston, Texas

  5. 5

    Laboratory Medicine, University of Texas M. D. Anderson Cancer Center, Houston, Texas

  6. 6

    Department of Anesthesiology, Duke University, Raleigh, North Carolina

  1. †

    Dr. Jean-Bernard Durand is on the speaker's bureaus for Scios, GlaxoSmithKline, and Novartis.

  2. ‡

    Fax: (713) 745-1942

*Department of Cardiology, Unit 449, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030

Publication History

  1. Issue published online: 19 JAN 2007
  2. Article first published online: 13 DEC 2006
  3. Manuscript Accepted: 11 NOV 2006
  4. Manuscript Revised: 9 OCT 2006
  5. Manuscript Received: 17 JUL 2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (162K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Miguel Ángel Sanz, Vicente Vicente García, Antonio Fernández, M. Fernanda López, Carlos Grande, Isidro Jarque, Rafael Martínez, María Eva Mingot, Emilio Monteagudo, Josep Ma Ribera, David Valcárcel, Diagnóstico, tratamiento y seguimiento de la trombocitopenia inmune primaria, Medicina Clínica, 2012, 138, 6, 261.e1

    CrossRef

  2. You have free access to this content2
    Syed Wamique Yusuf, Nicoleta Daraban, Nadia Abbasi, Xiudong Lei, Jean-Bernard Durand, Iyad N. Daher, Treatment and Outcomes of Acute Coronary Syndrome in the Cancer Population, Clinical Cardiology, 2012, 35, 5
    Direct Link:
  3. 3
    T G DeLoughery, Between scylla and charybdis: antithrombotic therapy in hematopoietic progenitor cell transplant patients, Bone Marrow Transplantation, 2011,

    CrossRef

  4. 4
    Lidia Boccardi, Fabiola Fini, Paolo Giuseppe Pino, Giovanni Minardi, Cardiopatie e rischio cardiovascolare in pazienti candidati alla terapia antitumorale. Che cosa deve sapere l’oncologo, Journal of Cardiovascular Echography, 2011, 21, 2, 45

    CrossRef

  5. 5
    Syed Wamique Yusuf, Nasreen A Ilias-Khan, Jean-Bernard Durand, Chemotherapy-induced cardiomyopathy, Expert Review of Cardiovascular Therapy, 2011, 9, 2, 231

    CrossRef

  6. 6
    Erlotinib or Gefitinib for Non–Small-Cell Lung Cancer, New England Journal of Medicine, 2011, 364, 24, 2367

    CrossRef

  7. 7
    Charles Porter, David Slosky, Interventional Strategies to Manage Heart Failure in Patients with Cancer, Heart Failure Clinics, 2011, 7, 3, 395

    CrossRef

  8. 8
    M. Noutsias, B. Maisch, Treatment of cardiovascular diseases in cancer patients, Herz, 2011, 36, 4, 340

    CrossRef

  9. 9
    Christine Rysler, Nadina Stoffel, Andreas Buser, Alois Gratwohl, Dimitrios A. Tsakiris, Martin Stern, Effect of beta-blockers, Ca2+antagonists, and benzodiazepines on bleeding incidence in patients with chemotherapy induced thrombocytopenia, Platelets, 2010, 21, 1, 77

    CrossRef

  10. 10
    Xiao Zhou, Shyam Teegala, Auris Huen, Yuan Ji, Luis Fayad, Fredrick B. Hagemeister, Gregory Gladish, Saroj Vadhan-Raj, Incidence and Risk Factors of Venous Thromboembolic Events in Lymphoma, The American Journal of Medicine, 2010, 123, 10, 935

    CrossRef

  11. 11
    Ronald J. Krone, Managing Coronary Artery Disease in the Cancer Patient, Progress in Cardiovascular Diseases, 2010, 53, 2, 149

    CrossRef

  12. 12
    Marc Cohen, Catalin Boiangiu, Mateen Abidi, Therapy for ST-Segment Elevation Myocardial Infarction Patients Who Present Late or Are Ineligible for Reperfusion Therapy, Journal of the American College of Cardiology, 2010, 55, 18, 1895

    CrossRef

  13. 13
    Edward T.H. Yeh, Courtney L. Bickford, Cardiovascular Complications of Cancer Therapy, Journal of the American College of Cardiology, 2009, 53, 24, 2231

    CrossRef

  14. 14
    M.F. Roizen, Impact of Aspirin Therapy in Cancer Patients With Thrombocytopenia and Acute Coronary Syndromes, Yearbook of Anesthesiology and Pain Management, 2008, 2008, 14

    CrossRef

  15. 15
    Syed Wamique Yusuf, Peter Razeghi, Edward T.H. Yeh, The Diagnosis and Management of Cardiovascular Disease in Cancer Patients, Current Problems in Cardiology, 2008, 33, 4, 163

    CrossRef

  16. 16
    Aarif Y Khakoo, Edward TH Yeh, Therapy Insight: management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy, Nature Clinical Practice Oncology, 2008, 5, 11, 655

    CrossRef

  17. 17
    Aspirin therapy is safe in cancer patients with ACS and thrombocytopenia, Nature Clinical Practice Oncology, 2007, 4, 7, 391

    CrossRef

  18. 18
    Robert P. Giugliano, Eugene Braunwald, The Year in Non–ST-Segment Elevation Acute Coronary Syndrome, Journal of the American College of Cardiology, 2007, 50, 14, 1386

    CrossRef

View Full Article (HTML) Get PDF (162K)